Linox 600 Tablet contains Linezolid 600 mg, an oxazolidinone-class antibiotic indicated for the treatment of serious bacterial infections caused by susceptible Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). It is primarily utilized in the management of complicated skin and soft tissue infections, nosocomial and community-acquired pneumonia, and other severe infections where alternative treatments are ineffective or contraindicated. Linezolid exerts its antibacterial effect by inhibiting bacterial protein synthesis through binding to the 23S ribosomal RNA of the 50S subunit, thereby preventing the formation of the initiation complex essential for bacterial translation. Linox 600 is administered orally, with excellent bioavailability, allowing for effective systemic concentrations. The dosing regimen should be tailored based on the severity of infection and patient-specific factors, typically administered twice daily. Caution is advised in patients with a history of myelosuppression, peripheral or optic neuropathy, and those receiving serotonergic agents due to the risk of serotonin syndrome. Common adverse effects include gastrointestinal disturbances, headache, and reversible myelosuppression. Regular monitoring of blood counts is recommended during prolonged therapy. Linox 600 Tablet should be used under strict medical supervision to ensure efficacy and minimize resistance development.

Dosage & How to Use